Published in Eur J Immunol on February 01, 1992
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J (2004) 3.17
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax (1999) 2.63
Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. Am J Respir Crit Care Med (2008) 1.67
Endoglin-targeted cancer therapy. Curr Drug Deliv (2011) 1.65
Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int (2012) 1.59
Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol (1996) 1.50
Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem (2007) 1.34
Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet (2003) 1.28
Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest (1997) 1.24
Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res (2006) 1.17
Tumour vasculature--a potential therapeutic target. Br J Cancer (1995) 1.14
Expression of normal and truncated forms of human endoglin. Biochem J (1999) 1.05
Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule. Clin Exp Immunol (1992) 0.90
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines. Cancer Immunol Res (2014) 0.90
Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy. Cancer Cell Microenviron (2015) 0.89
Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One (2014) 0.88
Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin. Biochem J (1994) 0.88
Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro. Am J Pathol (2014) 0.85
Endoglin - a marker of vascular endothelial cell proliferation in cancer. Contemp Oncol (Pozn) (2012) 0.84
Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction. PLoS One (2011) 0.84
Endoglin deficiency impairs stroke recovery. Stroke (2014) 0.84
Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med (2010) 0.83
Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. Mediators Inflamm (2014) 0.83
An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia. PLoS One (2013) 0.82
Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure. Int J Rheumatol (2010) 0.82
Biology of renal tumour cancer stem cells applied in medicine. Contemp Oncol (Pozn) (2015) 0.80
Endoglin in liver fibrogenesis: Bridging basic science and clinical practice. World J Biol Chem (2014) 0.78
Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia. Am J Reprod Immunol (2012) 0.77
Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders. Clin Exp Immunol (1995) 0.77
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. Oncogene (2016) 0.76
Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response. PLoS Genet (2016) 0.75
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A (1982) 7.16
The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol (1983) 4.17
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem (1992) 3.57
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol (1984) 3.26
Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol (1992) 3.07
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem (1999) 2.77
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet (2005) 2.72
Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem (1996) 2.72
A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest (1999) 2.64
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax (1999) 2.63
VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization. Eur J Immunol (1986) 2.31
LFA-1 and Lyt-2,3, molecules associated with T lymphocyte-mediated killing; and Mac-1, an LFA-1 homologue associated with complement receptor function. Immunol Rev (1982) 2.23
Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies. Hybridoma (1982) 2.14
Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol (1998) 2.06
Beta 2-microglobulin from serum associates with MHC class I antigens on the surface of cultured cells. Nature (1984) 2.05
Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem (1990) 2.04
Organization and expression strategy of the ambisense genome of densonucleosis virus of Galleria mellonella. J Virol (2003) 1.95
[Castleman's disease: description and comments on 3 cases]. Med Clin (Barc) (1994) 1.95
Mild cognitive impairment: directions for future research. Neurology (2003) 1.78
Nascent polypeptide chains emerge from the exit domain of the large ribosomal subunit: immune mapping of the nascent chain. Proc Natl Acad Sci U S A (1982) 1.69
Interaction of leukocyte integrins with ligand is necessary but not sufficient for function. J Cell Biol (1992) 1.68
Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol (2000) 1.64
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res (1995) 1.62
Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol (2001) 1.61
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science (1989) 1.60
Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol (1988) 1.59
Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus. Nature (1984) 1.57
Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol (1996) 1.50
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J (2000) 1.50
Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem (1998) 1.44
Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: a comparison of proxy reports and objective measures. J Gerontol B Psychol Sci Soc Sci (2001) 1.42
Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur J Immunol (1987) 1.41
Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum (2002) 1.40
Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity. J Immunol (1983) 1.39
Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology (1997) 1.38
Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics (1988) 1.37
Stable hamster-mouse hybridomas producing IgG and IgM hamster monoclonal antibodies of defined specificity. J Immunol (1983) 1.36
Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet (2000) 1.31
CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest (2001) 1.30
Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol (1993) 1.29
Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol (1986) 1.28
Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol (1992) 1.28
Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J Immunol (1988) 1.26
Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest (1997) 1.24
Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant (1994) 1.24
Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease). J Am Acad Dermatol (2002) 1.24
CD 105 and angiogenesis. J Pathol (1996) 1.23
A glycoprotein of molecular weight 85,000 on human cells of B-lineage: detection with a family of monoclonal antibodies. Mol Immunol (1985) 1.22
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol (2000) 1.22
Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology (1994) 1.21
Paxillin localizes to the lymphocyte microtubule organizing center and associates with the microtubule cytoskeleton. J Biol Chem (2000) 1.19
Antigens involved in mouse cytolytic T-lymphocyte (CTL)-mediated killing: functional screening and topographic relationship. Cell Immunol (1982) 1.18
Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow. Microcirculation (2000) 1.16
Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res (2000) 1.16
Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet (2006) 1.15
Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood (2001) 1.14
Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet (1999) 1.13
ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol (1997) 1.13
Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol (1985) 1.12
Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway. J Immunol (1992) 1.12
The acidic proteins of eukaryotic ribosomes. A comparative study. Biochim Biophys Acta (1981) 1.11
Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci (1996) 1.11
Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons. Eur J Neurosci (2001) 1.10
Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem (1995) 1.09
An evaluation of the NINCDS-ADRDA neuropsychological criteria for the assessment of Alzheimer's disease: a confirmatory factor analysis of single versus multi-factor models. J Clin Exp Neuropsychol (2001) 1.09
Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res (1994) 1.09
The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol (2000) 1.09
Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med (2000) 1.08
Gelatinous degeneration presenting as a preleukaemic syndrome. J Clin Pathol (1996) 1.08
Structural and functional studies on the interaction of sodium dodecyl sulfate with beta-galactosidase. Arch Biochem Biophys (1993) 1.07
Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. J Periodontol (2001) 1.06
Delayed neutrophil apoptosis in chronic periodontitis patients. J Clin Periodontol (2003) 1.05
Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet (2001) 1.05
Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol (2001) 1.04
Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res (1995) 1.04
Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis (2000) 1.04
Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod (1994) 1.04
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res (1991) 1.03
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J (2004) 1.03
Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res (2001) 1.02
Plasma-cell granuloma of the gingiva. Oral Surg Oral Med Oral Pathol (1977) 1.02
Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Res (2000) 1.02
Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry (2000) 1.02
Functional relevance during lymphocyte migration and cellular localization of activated beta1 integrins. Eur J Immunol (1997) 1.02
Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet (2003) 1.01
Cellular and humoral reactivity pattern to the mycobacterial heat shock protein HSP65 in adjuvant arthritis susceptible and resistant Wistar rats. Autoimmunity (1991) 1.01
Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol (1991) 1.01
Assignment of the human endoglin gene (END) to 9q34-->qter. Cytogenet Cell Genet (1993) 1.00